Navigation Links
Hemophilia Pipeline Overview - Once-a-week prophylaxis may soon become a reality
Date:12/13/2012

recombinant compounds can only gain significant market share by either addressing the lack of long-acting recombinant factor IX therapeutics or by addressing the need for more competitively priced recombinant products.

Economy of scale plays a role when producing a biologic compound cost-effectively and established companies will have an advantage in this area; having the right infrastructure, production facilities, marketing channels, and sales force are important factors that will determine whether a company can successfully enter the hemophilia market.

Datamonitor's up to date key pipeline hemophilia A and B therapeutics profiles includes the latest clinical data and industry developments.Understand the most pressing unmet needs in hemophilia and how current pipeline products can gain significant market share by addressing them.Compare pipeline products with current gold-standard treatments and assess what they will have to do to deliver growth.

OVERVIEW

Catalyst

Summary

Clinical Pipeline Overview

A handful of key players dominate the market

Gene therapy looks hopeful but market entry is still not predicted for this decade

Current Gold-Standard Product Profiles

Kogenate FS (FVIII recombinant; Bayer): the gold-standard hemophilia A therapy

BeneFIX (FIX recombinant; Pfizer): the gold-standard hemophilia B therapy

Target product profile versus current level of attainment

Key Factor VIII Pipeline Products

NN7008 (turoctocog alfa; Novo Nordisk)

BIIB 031 (rFVIIIFc; Biogen Idec)

NN7088 (rFVIII, glycopegylated; Novo Nordisk)

BAY-94-9027 (recombinant PEGylated factor VIII; Bayer)

Clinical and commercial attractiveness for key hemophilia A pipeline products

Key Factor IX Pipeline Products

BAX 326 (
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
2. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
3. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
4. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
5. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
9. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
10. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
11. Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
(Date:5/23/2013)... and PARIS , May 23, ... a leading developer and manufacturer of precision guided therapy ... coronary and peripheral vascular disease, today announced preliminary results ... I ndependent S tenosis E valuation) ... trial session at EuroPCR 2013. These prospective results confirm ...
(Date:5/23/2013)... 22. Mai 2013 Ranbaxy ... Tochtergesellschaft von Daiichi Sankyo Co., Ltd. ... 22. Mai die Maßnahmen bekannt, die ... hat, um sich der Angelegenheiten der ... http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi Sankyo ...
Breaking Medicine Technology:InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... , July 27 BioElectronics Corp. (Pink Sheets: ... its distribution partner for Japan , YesDTC Holdings, Inc. ... staff of the pending review by Japanese government medical device ... review will take place on Wednesday, July 28th . ...
... , July 27 Codexis, Inc. (Nasdaq: CDXS ) today ... Leadership Forum, August 8-10, 2010 in Vail, CO. ... presentation on August 10 at 8:30 am Mountain Time . ... www.codexis.com .   , , ...
Cached Medicine Technology:BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date 2Codexis to Present at the Pacific Crest Technology Leadership Forum 2
(Date:5/23/2013)... A new report estimates that upgrading ... save $2.1 billion without reducing access or the quality ... Florida and other state Medicaid programs could make more ... on to curb wasteful pharmacy spending. , Learn ... MedicaidPharmacySavings.com . , “The easiest way for Florida to ...
(Date:5/23/2013)... Looking for tips on how to avoid a ... caring for your aging parent? Today the ... the results of a survey of 335 geriatric care managers ... Here are the top 5 tips identified by these aging ... respondents selecting each option): , 1.    Give each family member opportunity ...
(Date:5/23/2013)... York, New York (PRWEB) May 23, 2013 ... year’s recall of Rejuvenate and ABG II Modular-Neck Hip Stems ... LLP notes that new research has found a connection between ... soft tissue destruction. The study, which was published on ... looked at 12 hips in 11 patients who reported ...
(Date:5/23/2013)... that the daily clearance of neutrophils from the body ... bone marrow into the bloodstream, according to a report ... are leukocytes (white blood cells) that defend the body ... perform their function, these cells release toxic substances when ... these substances in the wrong place by damaged neutrophils ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill ... calories with simple tips from Retrofit weight loss . ... summer. , “The powerful heat of the grill can be ... are not mindful of your selections, it can be as ... Amy Margulies. , Margulies advises clients to choose healthy options ...
Breaking Medicine News(10 mins):Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3
... March 22, 2012, New York, NYAs the second anniversary ... Fund report finds that 49 states and the District ... implementation, such as passing legislation, issuing regulations or other ... reforms in the law include new rules for insurers ...
... , WEDNESDAY, March 21 (HealthDay News) -- When used ... as acupuncture, acupressure and dietary changes may spell significant ... study suggests. The authors say that their study ... combining Western medicine with Eastern therapies among these patients, ...
... HealthDay Reporter , WEDNESDAY, March 21 (HealthDay News) -- Men ... tissue taken from both bald and hairier spots on men,s ... loss. The researchers note that drugs that inhibit the ... could one day be used to help men preserve their ...
... team of researchers led by A. K. Rajasekaran, PhD, Director ... that a key protein involved in cell function and regulation ... Their work is published online in the American Journal ... Cigarette smoke is well recognized as a cause of ...
... March 21, 2012: Anxiety, depression, stress and ... use in youth, according to a study from Carolyn ... from the University of Washington and Seattle University. ... grade who felt more emotional support from teachers reported ...
... March 20, 2012) Ching-Hon Pui, M.D., a renowned leader ... recipient of the 2012 Pediatric Oncology Award from the American ... contributions to better understanding the blood cancer,s biology and treatment ... Pui will receive the award in June at the ...
Cached Medicine News:Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 2Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 3Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 4Health News:Alternative Medicine May Help Ease Chronic Sinusitis 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 3Health News:Research Spots Potential New Target in Fight Against Baldness 2Health News:Research Spots Potential New Target in Fight Against Baldness 3Health News:Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke 2Health News:Middle school teacher support lowers risk for early alcohol use 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 3
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: